Clinical Trials
7 trialsNCT04211259 2026-05-29
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Recruiting
NCT07101445 2026-02-10
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Emory University
Phase 4 Recruiting
NCT07300735 2025-12-29
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Alexandria University
Phase NA Recruiting
NCT06265077 2024-12-13
Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients
Mansoura University
Phase 1/2 Completed
NCT05190627 2022-01-27
LORALAM
Institut d'Investigació Biomèdica de Bellvitge
Phase 2 Unknown
NCT02392039 2019-04-23
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02305979 2018-07-03
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
Wake Forest University Health Sciences
Completed